Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (73.36 KB, 1 trang )
Alter MJ. Prevention of spread of hepatitis C. Hepatology 2002;36(5 suppl
1):S93–S98.
Mack CL, Gonzalez-Peralta RP, Gupta N, et al; North American Society for
Pediatric Gastroenterology, Hepatology, and Nutrition. NASPGHAN
practice guidelines: diagnosis and management of hepatitis C infection in
infants, children, and adolescents. J Pediatr Gastroenterol Nutr
2012;54(6):838–855.
Murray KF, Balistreri WF, Bansal S, et al. Safety and Efficacy of LedipasvirSofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children
Ages 6–11. Hepatology 2018;68:2158–2166.
NIH consensus statement on management of hepatitis C: 2002. NIH Consens
State Sci Statements 2002;19(3):1–46.
Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in
asymptomatic patients. N Engl J Med 2000;342(17):1266–1271.
Sokal EM, Bortolotti F. Update on prevention and treatment of viral hepatitis
in children. Curr Opin Pediatr 1999;11(5):384–389.
Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis,
and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.
Hepatology 2018;67:1560–1599.
Gastroesophageal Reflux Disease
Lightdale JR, Gremse DA. Gastroesophageal reflux: management guidance
for the pediatrician. Pediatrics 2013;131(5):e1684–e1695.
Mousa H, Hassan M. Gastroesophageal Reflux Disease. Pediatr Clin N Am
2017;64(3):487–505.
Vandenplas Y, Rudolph CD, Di Lorenza C, et al. Pediatric gastroesophageal
reflux clinical practice guidelines: joint recommendations of the North
American Society for Pediatric Gastroenterology, Hepatology, and Nutrition
(NASPGHAN) and the European Society for Pediatric Gastroenterology,
Hepatology and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr
2009;49(4):498–547.
Celiac Disease
Garnier-Lengliné H, Cerf-Bensussan N, Ruemmele FM. Celiac disease in